Publications found:
75
Sort by:
Natural Killer Cells Therapeutics Market Report by Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), End User (Hospitals, Research Centers and Institutes, and Others), and Region 2026-2034
US$ 3,999.00
The global natural killer cells therapeutics market size reached USD 3.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.2 Billion by 2034, exhibiting a growth rate (CA...
June 2026
147 pages
Cell Therapy Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Autologous, Allogenic), By Therapeutic Area (Oncology, Cardiovascular Diseases, Musculoskeletal Disorders, Dermatology), By Region & Competition, 2021-2031F
US$ 4,500.00
The global cell therapy market is projected to expand significantly, from USD 6.74 billion in 2025 to USD 13.32 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 12.02%. This grow...
May 2026
185 pages
Cellular Immunotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End-Use (Hospitals, Cancer Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cellular Immunotherapy Market is projected to expand from USD 7.61 Billion in 2025 to USD 13.51 Billion by 2031, reflecting a compound annual growth rate of 10.04%. This specialized therape...
May 2026
180 pages
Engineered T Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Chimeric Antigen Receptor, T Cell Receptor, Tumor-Infiltrating Lymphocytes), By Application (Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Melanoma), By End-User (Cancer Research Centers, Clinics, Hospitals, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Engineered T Cells Market is projected to expand significantly, growing from USD 6.23 Billion in 2025 to USD 12.74 Billion by 2031, demonstrating a compound annual growth rate of 12.66%. En...
May 2026
185 pages
Global CAR-T Cell Therapy Market Growth 2026-2032
US$ 3,660.00
The global CAR-T Cell Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for CAR-T C...
May 2026
94 pages
Cell Therapy Market - 2024-2033
US$ 2,999.00
The Cell Therapy Market was valued at US$ 6.52 Billion in 2024 and is anticipated to reach US$ 48.98 Billion by 2033, at a CAGR of 0.214 from 2026 to 2032. The report delivers in-depth insights into k...
March 2026
210 pages
Global CAR T-Cell Therapy Market Size Study and Forecast by Product (Abecma, Breyanzi, Carvykti, Kymriah), Disease Indication (Lymphoma, Leukemia, Multiple Myeloma), End Use (Hospitals, Specialty Cancer Centers, Academic & Research Institutes), and Regional Forecasts 2025–2035
US$ 3,750.00
Chimeric Antigen Receptor (CAR) T-cell therapy represents a transformative class of personalized immunotherapies designed to genetically engineer a patient’s own T-cells to recognize and eliminate can...
March 2026
293 pages
Cell Therapy Human Raw Materials Market Size, Share & Trends Analysis Report By Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents & Buffers), By End Use (CROs & CMOs, Academic & Research Institutions), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global cell therapy human raw materials market was size valued at USD 4.37 billion in 2025 and is projected to reach USD 16.79 billion by 2033, expanding at a CAGR of 18.44% from 2026 to 2033. The...
February 2026
120 pages
India CAR-T Cell Therapy Market - 2024-2033
US$ 2,999.00
The India CAR-T Cell Therapy Market was valued at US$ 534.80 Million in 2024 and is anticipated to reach US$ 1,215.68 Million by 2033, at a CAGR of 0.097 from 2026 to 2032. The report delivers in-dept...
February 2026
210 pages
Japan Cell Therapy Market - 2024-2033
US$ 2,999.00
The Japan Cell Therapy Market was valued at US$ 416.83 Million in 2024 and is anticipated to reach US$ 1,632.99 Million by 2033, at a CAGR of 0.165 from 2026 to 2032. The report delivers in-depth insi...
February 2026
218 pages
Japan CAR-T Cell Therapies Market - 2024-2033
US$ 2,999.00
The Japan CAR-T Cell Therapies Market was valued at US$ 346.00 million in 2024 and is anticipated to reach US$ 1,350.15 million by 2033, at a CAGR of 0.163 from 2026 to 2032. The report delivers in-de...
February 2026
218 pages
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
US$ 4,950.00
The global CAR T-cell therapy market is projected to reach USD 13.78 billion in 2031 from USD 7.24 billion in 2026, at a CAGR of 13.7%. Market growth is primarily driven by rising global cancer preval...
February 2026
320 pages
US CAR-T Cell Therapy Market - 2024-2033
US$ 2,999.00
The US CAR-T Cell Therapy Market was valued at US$ 3.42 billion in 2024 and is anticipated to reach US$ 9.85 billion by 2033, at a CAGR of 0.127 from 2026 to 2032. The report delivers in-depth insight...
February 2026
213 pages
Cell and Gene Therapy Tools and Reagents: Global Markets
US$ 4,650.00
The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate...
February 2026
175 pages
CAR T-cell Therapy Market Size, Share & Trends Analysis Report By Product (Abecma, Breyanzi, Carvykti, Kymriah), By Disease Indication (Lymphoma, Leukemia, Multiple Myeloma), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global CAR T-cell therapy market size was estimated at USD 5.82 billion in 2025 and is projected to reach USD 22.36 billion by 2033, growing at a CAGR of 18.06% from 2026 to 2033. Market growth is...
February 2026
150 pages
Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2026-2034
US$ 3,999.00
The global cell therapy market size was valued at USD 18.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 61.0 Billion by 2034, exhibiting a CAGR of 14.55% during 2026...
February 2026
141 pages
Cell Therapy CDMO Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Other Service Types), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The cell therapy CDMO market size is expected to grow from US$ 4.12 billion in 2024 to US$ 21.92 billion by 2031; it is projected to register a CAGR of 27.1% during 2025-2031. The increasing prevalenc...
January 2026
217 pages
